Clinical trials for Cancer in United States

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Study ID: NCT05425004

Sponsor

Baptist Health South Florida

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Study ID: NCT04139304

Sponsor

AIDS Malignancy Consortium

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas with Child-Pugh-B Cirrhosis

Study ID: NCT06526104

Sponsor

The University of Texas Health Science Center at San Antonio

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

Study ID: NCT06709404

Sponsor

Wake Forest University Health Sciences

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

Study ID: NCT05296304

Sponsor

Memorial Sloan Kettering Cancer Center

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Study ID: NCT05039801

Sponsor

M.D. Anderson Cancer Center

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Study ID: NCT05665504

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

Study ID: NCT02638701

Sponsor

University of California, San Francisco

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

Study ID: NCT06789601

Sponsor

Brigham and Women's Hospital

Magnetic Resonance Imaging of Breast Cancer

Study ID: NCT01035112

Sponsor

Stanford University